RS50903B - Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera - Google Patents

Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera

Info

Publication number
RS50903B
RS50903B YUP-437/00A YU43700A RS50903B RS 50903 B RS50903 B RS 50903B YU 43700 A YU43700 A YU 43700A RS 50903 B RS50903 B RS 50903B
Authority
RS
Serbia
Prior art keywords
formula
carbon atoms
pyridone
alkyl
residue
Prior art date
Application number
YUP-437/00A
Other languages
English (en)
Serbian (sr)
Inventor
Manfred Bohn
Karl Theodor Kraemer
Original Assignee
Sanofi-Aventis Deutschland Gmbh.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh. filed Critical Sanofi-Aventis Deutschland Gmbh.
Publication of YU43700A publication Critical patent/YU43700A/sh
Publication of RS50903B publication Critical patent/RS50903B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
YUP-437/00A 1998-01-24 1999-01-11 Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera RS50903B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19802708A DE19802708A1 (de) 1998-01-24 1998-01-24 Verwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren

Publications (2)

Publication Number Publication Date
YU43700A YU43700A (sh) 2003-08-29
RS50903B true RS50903B (sr) 2010-08-31

Family

ID=7855595

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-437/00A RS50903B (sr) 1998-01-24 1999-01-11 Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera

Country Status (27)

Country Link
US (1) US6534528B1 (enExample)
EP (1) EP1049468B1 (enExample)
JP (1) JP5127091B2 (enExample)
KR (1) KR100597332B1 (enExample)
CN (1) CN1128619C (enExample)
AR (1) AR016445A1 (enExample)
AT (1) ATE360418T1 (enExample)
AU (1) AU752406B2 (enExample)
BR (1) BR9907734A (enExample)
CA (1) CA2319359C (enExample)
CY (1) CY1106684T1 (enExample)
DE (2) DE19802708A1 (enExample)
DK (1) DK1049468T3 (enExample)
ES (1) ES2285829T3 (enExample)
HR (1) HRP20000496A2 (enExample)
HU (1) HU228824B1 (enExample)
IL (1) IL137453A (enExample)
ME (1) MEP55908A (enExample)
NZ (1) NZ505898A (enExample)
PL (1) PL192550B1 (enExample)
PT (1) PT1049468E (enExample)
RS (1) RS50903B (enExample)
RU (1) RU2212239C2 (enExample)
SI (1) SI1049468T1 (enExample)
SK (1) SK285350B6 (enExample)
TR (1) TR200002118T2 (enExample)
WO (1) WO1999037300A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001122804A (ja) * 1999-10-28 2001-05-08 Sato Pharmaceutical Co Ltd リン酸コーンスターチ配合外用医薬組成物
EP1354586A1 (en) * 2002-04-20 2003-10-22 Aventis Pharma Deutschland GmbH The use of hydroxpyridone-derivatives in wound healing
US20060257439A1 (en) * 2005-03-29 2006-11-16 Sabnis Ram W Cleansing compositions with color changing indicator
RU2326665C1 (ru) * 2007-04-03 2008-06-20 Марвел ЛайфСайнсез Лимитед, Великобритания Средство, обладающее противогипоксическим, противоинсультным, улучшающим память действием
ES2525387T3 (es) * 2010-07-27 2014-12-23 Clariant Finance (Bvi) Limited Composiciones que contienen peróxido de hidrógeno o sustancias que ponen en libertad peróxido de hidrógeno
BR112013001953A2 (pt) * 2010-07-27 2018-05-15 Clariant Finance Bvi Ltd uso de hidroxipiridonas ou sais dos mesmos para a estabilização de peróxido de hidrogênio ou substâncias doadoras de peróxido de hidrogênio
RS61907B1 (sr) 2015-04-06 2021-06-30 Subdomain Llc Polipeptidi koji sadrže de novo vezujući domen i njihova primena

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540218A (en) 1947-08-25 1951-02-06 Squibb & Sons Inc 2-hydroxy-pyridine-n-oxide and process for preparing same
AR242187A1 (es) * 1986-04-18 1993-03-31 Hoechst Ag Procedimiento para la preparacion de 1-hidroxi-2-piridonas, obtencion de medicamentos que las contienen, e intermediarios utiles en dicho procedimiento.
JPS63264504A (ja) * 1987-04-17 1988-11-01 Shinto Paint Co Ltd 工業用防カビ組成物
US4956184A (en) * 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
CA2046801C (en) * 1990-08-07 2002-02-26 Peter D. Davis Substituted pyrroles
DE4333893A1 (de) 1993-10-05 1995-04-06 Hoechst Ag Kosmetische Zubereitungen
PT865278E (pt) * 1995-12-04 2002-10-31 Aventis Pharma Gmbh Utilizacao de 1-hidroxi-2-piridonas para o tratamento de doencas terapeuticamente dificeis de mucosidade da pele

Also Published As

Publication number Publication date
DK1049468T3 (da) 2007-07-30
HUP0200851A1 (hu) 2002-07-29
HRP20000496A2 (en) 2000-12-31
DE19802708A1 (de) 1999-07-29
TR200002118T2 (tr) 2000-12-21
YU43700A (sh) 2003-08-29
PL192550B1 (pl) 2006-11-30
ME00390B (me) 2011-05-10
WO1999037300A1 (de) 1999-07-29
AU752406B2 (en) 2002-09-19
CA2319359A1 (en) 1999-07-29
AR016445A1 (es) 2001-07-04
SK285350B6 (sk) 2006-11-03
JP2002501020A (ja) 2002-01-15
US6534528B1 (en) 2003-03-18
EP1049468B1 (de) 2007-04-25
AU2278799A (en) 1999-08-09
ATE360418T1 (de) 2007-05-15
IL137453A (en) 2005-11-20
EP1049468A1 (de) 2000-11-08
HU228824B1 (en) 2013-05-28
NZ505898A (en) 2002-06-28
PL342055A1 (en) 2001-05-21
BR9907734A (pt) 2000-10-17
MEP55908A (en) 2011-05-10
SI1049468T1 (sl) 2007-08-31
PT1049468E (pt) 2007-05-31
CA2319359C (en) 2008-03-18
CY1106684T1 (el) 2012-05-23
KR20010034325A (ko) 2001-04-25
IL137453A0 (en) 2001-07-24
ES2285829T3 (es) 2007-11-16
DE59914312D1 (de) 2007-06-06
SK10892000A3 (sk) 2000-12-11
HUP0200851A3 (en) 2003-05-28
CN1128619C (zh) 2003-11-26
CN1288380A (zh) 2001-03-21
KR100597332B1 (ko) 2006-07-10
JP5127091B2 (ja) 2013-01-23
RU2212239C2 (ru) 2003-09-20
HK1034447A1 (en) 2001-10-26

Similar Documents

Publication Publication Date Title
JP6778219B2 (ja) 皮膚の炎症を抑制するイガイ接着タンパク質製品及びその適用
JP4010574B2 (ja) 皮膚外用剤
JP2010077143A (ja) 創傷治療用外用剤
CN100420439C (zh) 双胍衍生物在制备具有瘢痕形成作用的医药产品中的应用
JP2019517533A (ja) 皮膚の種々の損傷創面の治療の外用医薬組成物およびその調製方法
JP2023080289A (ja) 慢性皮膚損傷の治療のための抗微生物剤とピルフェニドンとを含有する局所用半固体組成物
RS50903B (sr) Primena preparata u obliku pudera koji sadrži hidroksipiridon za tretman ulkusa na potkolenici ili dekubitusnog ulcera
EP3207943B1 (en) Therapeutic material for skin ulcer
JP2014526487A (ja) 種々の原因の末梢性潰瘍の治療用組成物
EP2570124B1 (en) Oleuropein compositions for healing wounds and ulcers in elderly people and/or diabetics
JPH05194214A (ja) 創傷治癒促進剤
CZ295316B6 (cs) Léčivo k léčbě bércových vředů a proleženin
MXPA00007000A (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
HK1034447B (en) Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
JP2007277135A (ja) 創傷治療用外用剤
JPH10120577A (ja) 創傷治療剤
KR20130103297A (ko) 활성 성분으로 l-카르니틴 또는 프로피오닐 l-카르니틴을 포함하는, 만성 정맥 기능부전의 예방 또는 치료용 복합 조성물